tiprankstipranks
Trending News
More News >

EMvision’s Director Acquires 200,000 Options

EMvision’s Director Acquires 200,000 Options

EMvision Medical Devices Ltd. (AU:EMV) has released an update.

Confident Investing Starts Here:

EMvision Medical Devices Ltd. has announced a change in director Patryk Kania’s interest, with the acquisition of 200,000 unlisted options at an exercise price of $3.15, set to expire on December 31, 2027. This move was approved during the company’s Annual General Meeting, indicating strategic positioning by the director.

For further insights into AU:EMV stock, check out TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App